Evin Uzun Jacobson
Dados Biográficos
| ID | 8930819 |
|---|---|
| NOME | Evin Uzun Jacobson |
| PRENOMES | Evin Uzun |
| SOBRENOME | Jacobson |
| ASSINATURA | JACOBSON E U |
| AFILIAÇÕES | Centers for Disease Control and Prevention |
| ORCID | 0000-0002-7052-5633 |
| VERIFICADO | Sim |
| TOTAL DE OBRAS | 2 |
| TOTAL DE CITAÇÕES | 0 |
| TOTAL COMO AUTOR | 2 |
| TOTAL COMO EDITOR | 0 |
| PRIMEIRO ANO DE PUBLICAÇÃO | 2021 |
| ANO MAIS RECENTE DE PUBLICAÇÃO | 2023 |
| ÍNDICE H | 0 |
Assessing the individual benefits of reducing HIV diagnosis delay and increasing adherence to HIV care and treatment
We used an agent-based simulation model (Progression and Transmission of HIV) to follow for 20 years a cohort of persons in the United States infected with HIV in 2015. We assessed the benefits of reducing the delay between HIV infection and diagnosis and increasing adherence to HIV care and treatment on the percent of persons surviving 20 years after infection, average annual HIV transmission rates, and time spent virally suppressed. We examined…
Optimal Allocation of Societal HIV Prevention Resources to Reduce HIV Incidence in the United States
Objectives. To optimize combined public and private spending on HIV prevention to achieve maximum reductions in incidence. Methods. We used a national HIV model to estimate new infections from 2018 to 2027 in the United States. We estimated current spending on HIV screening, interventions that move persons with diagnosed HIV along the HIV care continuum, pre-exposure prophylaxis, and syringe services programs. We compared the current funding allo…
Sem obras proeminentes nesta página.
Optimal Allocation of Societal HIV Prevention Resources to Reduce HIV Incidence in the United States
Objectives. To optimize combined public and private spending on HIV prevention to achieve maximum reductions in incidence. Methods. We used a national HIV model to estimate new infections from 2018 to 2027 in the United States. We estimated current spending on HIV screening, interventions that move persons with diagnosed HIV along the HIV care continuum, pre-exposure prophylaxis, and syringe services programs. We compared the current funding allo…
Assessing the individual benefits of reducing HIV diagnosis delay and increasing adherence to HIV care and treatment
We used an agent-based simulation model (Progression and Transmission of HIV) to follow for 20 years a cohort of persons in the United States infected with HIV in 2015. We assessed the benefits of reducing the delay between HIV infection and diagnosis and increasing adherence to HIV care and treatment on the percent of persons surviving 20 years after infection, average annual HIV transmission rates, and time spent virally suppressed. We examined…
HIV, Drug Use, Sexual Risk (2 obras) · HIV/AIDS Research and Interventions (2 obras) · Medicine (2 obras) · Business (1 obras) · Cohort (1 obras) · Cohort study (1 obras) · Demography (1 obras) · Drop out (1 obras) · Environmental health (1 obras) · Family medicine (1 obras)